Article
Copy number variation in glutathione-S-transferase T1 and M1 predicts incidence and 5-year survival from prostate and bladder cancer, and incidence of corpus uteri cancer in the general population.
The pharmacogenomics journal - 1 Aug 2011
Nørskov M S, Frikke-Schmidt R, Bojesen S E, Nordestgaard B G, Loft S, Tybjærg-Hansen A
Abstract excerpt
Glutathione-S-transferase T1 (GSTT1) and GSTM1 detoxify carcinogens and thus potentially contribute to inter-individual susceptibility to cancer. We determined the ability of GST copy number variation (CNV) to predict the risk of cancer in the general population. Exact copy numbers of GSTT1 and GSTM1 were measured by real-time PCR in 10 247 individuals, of whom 2090 had cancer. In men, the cumulative incidence of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.